Start Your Risk-Free Trial

Stargardt Macular Dystrophy (ABCA4) Medication Savings with TheDrugClub

Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.

  1. Join TheDrugClub as a member
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available discount pricing

About Stargardt Macular Dystrophy (ABCA4)

Stargardt Macular Dystrophy (ABCA4) is a genetic eye disorder causing progressive central vision loss, often starting in childhood or adolescence. It affects the macula, crucial for sharp, detailed vision. While there's no cure yet, managing the condition and its associated costs is vital. TheDrugClub helps members afford necessary medications and treatments, easing the financial burden for individuals and families facing this challenge.

Stargardt Macular Dystrophy (ABCA4) is an inherited eye disease that leads to progressive damage of the macula, the small central part of the retina responsible for sharp, detailed vision. This genetic condition is primarily caused by mutations in the ABCA4 gene, which plays a critical role in clearing waste products from the photoreceptor cells in the retina. When this gene malfunctions, a fatty yellow pigment called lipofuscin accumulates in the retinal pigment epithelium (RPE) cells, essentially poisoning them and leading to the degeneration of photoreceptors.

Symptoms typically begin in childhood or adolescence, though adult-onset forms exist. Individuals may experience blurred or distorted central vision, blind spots, difficulty adapting to dim light, and problems with color perception. Over time, central vision can significantly decline, often leading to legal blindness. Diagnosis usually involves a thorough eye exam, specialized imaging tests like optical coherence tomography (OCT) and fundus autofluorescence, and genetic testing to confirm the ABCA4 mutation.

Currently, there

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

Related conditions

Participating pharmacy savings paths

Start Your Risk-Free Trial
Start Your Risk-Free Trial